Apnimed, Inc. (BOATS:APMD) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Paul Sekhri Other companies: vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Axcella Health Inc (Director · May 19, 2022 – May 19, 2022 · Past); Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Jan 2, 2020 · Past) | Director · Since at least Jul 30, 2026 |
| William A Jones Jr Other companies: Annexon, Inc. (Director · Since at least Jan 9, 2025); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); NewAmsterdam Pharma Company N.V. (Chief Commercial Officer · Apr 25, 2024 – Jan 7, 2025 · Past); Akili Inc (Director · Aug 19, 2022 – May 2, 2023 · Past); Biohaven Pharmaceutical Holding Co Ltd (CCO-Migraine & Common Disease · Apr 1, 2019 – Oct 3, 2022 · Past); Nitromed Inc (Vice President · Aug 16, 2006 – Sep 16, 2007 · Past) | Director · Since at least Jul 30, 2026 |
| Gary Sender Other companies: iBio, Inc. (Director · Since at least Oct 14, 2020); Harmony Biosciences Holdings, Inc. (Director · Since at least Aug 18, 2020); Schrodinger, Inc. (Board Member · Since at least Feb 5, 2020); Nabriva Therapeutics AG (Chief Financial Officer · Dec 30, 2016 – Feb 28, 2021 · Past); Synergy Pharmaceuticals Inc (EVP and CFO · Nov 16, 2015 – Nov 16, 2015 · Past) | Director · Since at least Jul 30, 2026 |
| Paul Fonteyne Other companies: Amylyx Pharmaceuticals, Inc. (Director · Since at least Jan 6, 2022); Apellis Pharmaceuticals, Inc. (Director · Since at least Apr 2, 2020); Covetrus Inc (Director · Jul 1, 2021 – Oct 13, 2022 · Past); AMAG Pharmaceuticals Inc (Director · Oct 8, 2019 – Nov 16, 2020 · Past); Adicet Bio, Inc. (Director · Jan 25, 2018 – Jun 3, 2020 · Past) | Director · Since at least Jul 30, 2026 |
| Kevin Lind Other companies: Avalo Therapeutics, Inc. (Director · Since at least Sep 22, 2025); Longboard Pharmaceuticals Inc (President and CEO, Director · Mar 11, 2021 – Dec 2, 2024 · Past); Arena Pharmaceuticals Inc (Executive VP and CFO · Jun 15, 2016 – Mar 1, 2020 · Past) | Chief Executive Officer · Since at least Jul 30, 2026 |
| John Yee Other companies: Tempest Therapeutics, Inc. (Director · Since at least Jun 4, 2026) | Senior Vice President, Medical Affairs · Since at least Nov 5, 2026 |
| Andrea Werner | Senior Vice President, Global Clinical Operations · Since at least Nov 5, 2026 |
| Barry Wohl | Chief Business Officer · Since at least Nov 5, 2026 |
| Beth Weinberg | Chief Regulatory and Safety Officer · Since at least Nov 4, 2026 |
| Dennis Molnar | President and Chief Operating Officer · Since at least Jul 30, 2026 |
| Graham Goodrich | Chief Commercial Officer · Since at least Nov 5, 2026 |
| Jennifer Patterson | Senior Vice President, Human Resources · Since at least Nov 5, 2026 |
| John Cronin | Chief Medical Officer · Since at least Nov 5, 2026 |
| Lawrence G Miller | Director · Since at least Jul 30, 2026 |
| Luigi Taranto Montemurro | Chief Scientific Officer · Since at least Nov 5, 2026 |
| Michael Kelly | Chief Financial Officer · Since at least Jul 30, 2026 |
| Steven Spector | Chief Legal Officer and Head of Corporate Affairs · Since at least Sep 8, 2026 |